TFX
Teleflex Incorporated
Healthcare · Medical Instruments & Supplies · NYQ
$129.84
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$5.8B
Total market value of the company
Trailing P/E
1,858.00
Expensive — high growth expected
Forward P/E
12.43
Based on estimated future earnings — lower means cheaper
Rev Growth
+32.3%
Year-over-year revenue change
Profit Margin
-47.4%
How much profit the company keeps from each dollar of revenue
ROE
0.0%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$143.00
+10% from current price — median analyst estimate
Recommendation
HOLD
Consensus view from 9 analysts covering this stock
About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

https://www.teleflex.com

Country: United States Employees: 15,500 Industry: Medical Instruments & Supplies
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
DISTRIBUTION
Smart money appears to be selling into strength — caution
Sharpe Ratio
-0.349
Returns do not compensate for the risk — negative edge
Kelly Fraction
-0.0410
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.328
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-19.3%
Historical annualised return based on price data
Max Drawdown
-58.9%
Largest peak-to-trough decline — the worst it has been
HMM State
BEAR
Statistical model detects bearish conditions
Days in State
25
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
0.82
Less volatile than the market — more defensive
52W High
$139.67
7% below the year high
52W Low
$100.18
30% above the year low
Avg Volume
846,567
Average daily shares traded — higher means easier to buy and sell
Short Ratio
2.4
Days it would take all short sellers to cover — higher means more crowded
Short % Float
8.2%
Moderate short interest
Div Yield
105.0%
Annual dividend as a percentage of the share price
EPS (TTM)
$0.07
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
88.79
Heavy leverage — higher financial risk if revenues decline
Current Ratio
2.55
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
0.96
Like current ratio but excludes inventory — stricter test
Gross Margin
55.3%
Revenue left after cost of goods — higher means pricing power
Operating Margin
8.4%
Profit from core operations before interest and tax
Free Cash Flow
$-3,678,500
Negative — the business is spending more than it generates
Revenue (TTM)
$2.1B
Total revenue over the last 12 months
Net Income
$1M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
9
Target High
$155.00
Target Median
$143.00
Target Low
$135.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.